Skip to main content

Table 1 Characteristics of the patients

From: Outcomes of tricuspid annuloplasty with and without prosthetic rings: a retrospective follow-up study

Characteristic

Annuloplasty without ring (De Vega procedure) (n = 34)

Annuloplasty with ring (n = 40)

P value

Age (yr ± SD)

47.2 ± 7.3

49.5 ± 8.7

0.241

Male

7

20.6 %

4

10.0 %

0.326

Preoperative NYHA ClassIII-IV

33

97.1 %

38

95.0 %

0.945

Preoperative TI grade

     

None (n)

0

0.0 %

0

0.0 %

0.131

Mild (n)

8

23.5 %

14

35.0 %

Moderate (n)

18

52.9 %

23

57.5 %

Severe (n)

8

23.5 %

3

7.5 %

Preoperative TS

0

0

0

0

 

Preoperative mitral valve disease

     

None (n)

0

0.0 %

0

0.0 %

0.808

Stenosis (n)

21

61.7 %

24

60.0 %

Insufficiency (n)

2

5.8 %

4

10.0 %

Stenosis and insufficiency (n)

11

32.4 %

12

30.0 %

Preoperative aortic valve disease

     

None (n)

17

50.0 %

21

52.5 %

0.98

Stenosis (n)

1

2.9 %

1

2.5 %

Insufficiency (n)

7

20.6 %

9

22.5 %

Stenosis and insufficiency (n)

9

26.5 %

9

22.5 %

Preoperative

     

LVEF

55.9 ± 9.1

58.1 ± 7.1

0.253

RVD

22.9 ± 5.1

21.9 ± 3.4

0.29

LVD

49.6 ± 6.66

47.9 ± 8.8

0.351

PASP

51.5 ± 16.6

49.9 ± 14.2

0.668

1 year Postoperative

     

LVEF

61.9 ± 10.0

61.0 ± 8.8

0.733

RVD

20.7 ± 2.9

20.0 ± 2.2

0.277

LVD

44.5 ± 5.6

45.6 ± 4.1

0.37

PASP

36.5 ± 7.4

36.0 ± 8.3

0.903

Concomitant procedures

     

MVR (n)

22

64.7 %

32

80.0 %

0.132

AVR (n)

0

0

0

0

MVR + AVR (n)

12

35.3 %

8

20.0 %

  1. AVR aortic valve replacement, LVEF left ventricular ejection fraction, LVD left ventricular diameter, RVD right ventricular diameter, MVR mitral valve replacement, NYHA New York Heart Association, PASP pulmonary arterial systolic pressure, SD standard deviation, TI tricuspid valve insuffiency, TS tricuspid valve stenosis